Medicine recalls
|
| |
| The United Kingdom: Class 3 Medicines Recall: Accord Healthcare Ltd, Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Accord Healthcare Ltd is recalling various batches of Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules after retesting showed out of specification results. The batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels. For details of the affected batch numbers, please refer to the website in MHRA.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-atomoxetine-10mg-18mg-25mg-40mg-60mg-80mg-100mg-hard-capsules-el-24-a-slash-25
In Hong Kong, Atama Capsules 10mg (HK-66751), Atama Capsules 18mg (HK-66752), Atama Capsules 25mg (HK-66753) and Atama Capsules 40mg (HK-66754) are pharmaceutical products registered by I&C (Hong Kong) Limited (I&C). The products are prescription-only medicines. As confirmed by I&C, the affected batches have not been imported into Hong Kong. Related news was previously issued by MHRA, and was posted on the Drug Office website on 6 Jun 2024.
Ends/Wednesday, Jul 3, 2024
Issued at HKT 17:45
|
| |
|
